Streetbeat News

Revenues

MSOS

The Benzinga Cannabis Capital Conference featured a panel titled 'Cannabis Financing 101: Understanding Loans, Investments, and Cash Flow, To Keep Your Business Running'. The panel focused on financial strategies for cannabis businesses.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:05 pm

COIN

HOOD

Piper Sandler analyst Patrick Moley maintains an Overweight rating on Robinhood Markets (HOOD) with a $27 price target, citing new trading features and expected revenue growth. Coinbase (COIN) is rated Neutral with a $245 price target, driven by increased trading volumes and higher crypto prices.

Portfolio Pulse from Anusuya Lahiri

October 08, 2024 | 6:04 pm

IOT

Analysts have provided a range of ratings for Samsara (NYSE:IOT) over the past three months, with a majority being indifferent. The average 12-month price target has increased to $43.92, indicating a positive outlook. Samsara has shown strong revenue growth but faces challenges with profitability and returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:01 pm

RDN

Radian Group (NYSE:RDN) has received mixed ratings from analysts, with recent upgrades in price targets. The company's financial performance is strong, with impressive revenue growth, net margin, and return on equity. Analysts have raised their price targets, reflecting positive sentiment.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

SCLX

Scilex Holding Company reported preliminary Q3 2024 net sales for ZTlido in the range of $11M-$13M, showing a 9%-29% year-over-year increase. Total product net sales are estimated at $12M-$14M, reflecting a 19%-39% growth compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 08, 2024 | 6:00 pm

TDOC

Teladoc Health (NYSE:TDOC) has been analyzed by 14 analysts, showing a range of perspectives from bullish to bearish. The average 12-month price target is $10.5, down from $16.00. Analysts have adjusted their ratings and price targets, reflecting recent developments. Teladoc faces challenges with revenue growth, net margin, ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

FUTU

Futu Holdings (NASDAQ:FUTU) has significantly outperformed the market over the past 5 years, with an annualized return of 59.76%. A $100 investment in FUTU 5 years ago would now be worth $1,036.71, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

HQY

HealthEquity (NASDAQ:HQY) has outperformed the market over the past 10 years with an average annual return of 16.03%, surpassing the market by 4.25% annually. A $1000 investment in HQY 10 years ago would now be worth $4,474.75.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 6:00 pm

ICLR

Icon (NASDAQ:ICLR) has significantly outperformed the market over the past 15 years, with an annualized return of 18.53%. A $1000 investment in ICLR 15 years ago would now be worth $12,763.95. This highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:30 pm

EFX

Equifax (NYSE:EFX) has delivered an average annual return of 12.75% over the past 20 years, outperforming the market by 4.23% annually. A $100 investment in EFX 20 years ago would be worth $1,098.68 today, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 08, 2024 | 5:30 pm